Oncolytic Viruses: Immune or Cytolytic Therapy?

Molecular Therapy - United States
doi 10.1038/mt.2014.94
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

An Overview on Oncolytic Viruses as Cancer Therapy

International Journal of Cancer Studies & Research
2017English

Micromanaging Oncolytic Viruses

Science-Business eXchange
2008English

Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment

Frontiers in Immunology
AllergyImmunology
2018English

Oncolytic Viruses: Overcoming Translational Challenges

Journal of Clinical Investigation
Medicine
2019English

Using Clinically Approved Cyclophosphamide Regimens to Control the Humoral Immune Response to Oncolytic Viruses

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2012English

Achieving Systemic Delivery of Oncolytic Viruses

Expert Opinion on Drug Delivery
Pharmaceutical Science
2019English

Triple Threat to Cancer: Rationale for Combining Oncolytic Viruses, MEK Inhibitors, and Immune Checkpoint Blockade

OncoImmunology
OncologyAllergyImmunology
2019English

Oncolytic Viruses: A Step Into Cancer Immunotherapy

Virus Adaptation and Treatment
VirologyInfectious DiseasesImmunology
2011English

Sensitivity of Breast Tumors to Oncolytic Viruses

2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy